Translational spotlight on variant-proofing tech for COVID and beyond

Innovations with the potential to stay ahead of future SARS-CoV-2 variants and other related emerging viruses include host targets that regulate viral entry and mAbs with activity across a range of sarbecoviruses, the subgenus of betacoronaviruses that includes SARS-CoV-2 and SARS-CoV.

Targets and technologies captured in BioCentury’s Distillery, a curated database of translational academic research from over 25 journals, provide a cross-section of preclinical work on broad-spectrum therapies that could help address a potential “SARS-CoV-3.” ...